With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing.
In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated.
These drugs are believed to last for a month or more and could give quick, temporary immunity to people at high risk of infection, such as health workers and housemates of someone with COVID-19. If they proved effective and if a vaccine doesn’t materialize or protect as hoped, the drugs might eventually be considered for wider use, perhaps for teachers or other groups.
“Our goal is to get something out as soon as possible” and to have hundreds of thousands of doses ready by fall, said Lilly’s chief scientific officer, Dr. Daniel Skovronsky. Lilly is testing two different, single-antibody drugs — one with the Canadian company AbCellera and another with a Chinese company, Junshi Biosciences. In July, Junshi said no safety concerns emerged in 40 healthy people who tried it and that larger studies were getting underway.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
If You Get Covid-19 Overseas, This Startup Will Bring You Home When Other Companies Won’tRun by a team straight out of a Tom Clancy novel, a new company aims to give international travelers peace of mind during the pandemic.
Weiterlesen »
After record-high deaths, COVID-19 hospitalizations decline in Inland EmpireLast week, both San Bernardino and Riverside counties reported record single-day tallies of coronavirus-related deaths.
Weiterlesen »
The Muslim Fashion Designer Making Hijabs For COVID-19 Frontline WorkersThe sanitary head scarves are easily washed and safely reused.
Weiterlesen »
Vaccines and asymptomatic spreaders may hold keys to answering Covid-19 mysteries, experts sayAs US leaders work to control the spread of coronavirus, researchers across the country -- and globe -- are working to answer the mysteries that remain around infections.
Weiterlesen »
Sinovac launches late-stage trial for potential COVID-19 vaccine in IndonesiaChina's Sinovac Biotech Ltd launched on Tuesday a late-stage human trial involving as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
Weiterlesen »